DR. HENRY GEWIRTZ, MD
Osteopathic Medicine at Fruit St, Boston, MA

License number
Massachusetts 73900
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
55 Fruit St, Boston, MA 02114
Phone
(617) 724-3650
(617) 724-3636 (Fax)
(617) 724-0287
(617) 726-2894 (Fax)

Personal information

See more information about HENRY GEWIRTZ at radaris.com
Name
Address
Phone
Henry Gewirtz, age 78
245 Concord Ave APT 21, Cambridge, MA 02138
Henry Gewirtz
Cambridge, MA
(617) 945-9090
Henry Gewirtz, age 79
81 Beechcroft St, Brighton, MA 02135
Henry Gewirtz, age 79
4 Starbuck Rd, Nantucket, MA 02554
(508) 228-3590
Henry Gewirtz
243-245 Concord Ave, Cambridge, MA 02138

Organization information

See more information about HENRY GEWIRTZ at bizstanding.com

Henry Gewirtz MD

55 Fruit St, Boston, MA 02114

Industry:
Cardiologist, Internist
Phone:
(617) 724-3650 (Phone)
Henry M. Gewirtz


Massachusetts General Hospital - Henry Gewirtz MD

55 Fruit St #5B, Boston, MA 02114

Categories:
Cardiology Physicians & Surgeons
Phone:
(617) 724-6750 (Phone)

Professional information

Henry Gewirtz Photo 1

Dr. Henry Gewirtz, Boston MA - MD (Doctor of Medicine)

Specialties:
Cardiology
Address:
Heart Center
55 Fruit St SUITE 5B, Boston 02114
(617) 724-6750 (Phone)
Procedures:
Ablation for Treatment of Cardiac Arrythmias, Cardiac Catheterization (incl. Coronary Angiography), Cardiac Imaging, Cardiac Myocardial Perfusion Imaging, Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair, Chest CT (incl. Heart and Lungs), Peripheral Artery Catheterization
Conditions:
Angina and Acute Coronary Syndrome, Aortic Aneurysm, Aortic Valve Disease, Arrhythmias (incl. Atrial Fibrillation), Cardiomegaly, Cardiomyopathy, Carotid Artery Disease, Congestive Heart Failure, Coronary Artery Disease (CAD), Heart Attack (Acute Myocardial Infarction), Hyperlipidemia, Hypertension, Hypotension, Mitral Valve Disease, Pericardial Disease, Septal Defect, Tricuspid Valve Disease
Certifications:
Cardiovascular Disease, 1977, Internal Medicine, 1976, Nuclear Medicine, 1992
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Heart Center
55 Fruit St SUITE 5B, Boston 02114
Massachusetts General Hospital
55 Fruit St, Boston 02114
Education:
Medical School
University At Buffalo State University Of New York School Of Medicine
Graduated: 1971
Boston University Hospital
Graduated: 1972
Georgetown/Va Hospital
Graduated: 1975
Victoria Genl Hospital Dalhousi
Graduated: 1977
Mass Genl Hospital Harvard
Graduated: 1978


Henry Gewirtz Photo 2

Henry Gewirtz, Boston MA

Specialties:
Internist
Address:
55 Fruit St, Boston, MA 02114
Education:
State University of New York, School of Medicine and Biomedical Sciences (Buffalo) - Doctor of Medicine*
Massachusetts General Hospital - Fellowship - Cardiology*
Georgetown University Hospital - Residency - Family Medicine*
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine*, American Board of Internal Medicine Sub-certificate in Cardiovascular Disease (Internal Medicine)*


Henry Gewirtz Photo 3

Henry Gewirtz, Boston MA

Specialties:
Internal Medicine, Cardiovascular Disease, Cardiology, Nuclear Cardiology
Work:
Massachusetts General Hospital
55 Fruit St, Boston, MA 02114
Education:
State University of New York at Buffalo (1971)


Henry Gewirtz Photo 4

Detection And Therapy Of Vulnerable Plaque With Fluorescent And/Or Radiolabeled Compositions

US Patent:
2006007, Apr 6, 2006
Filed:
Aug 9, 2002
Appl. No.:
10/216026
Inventors:
Alan Fischman - Boston MA, US
Michael Hamblin - Boston MA, US
Ahmed Tawakol - Boston MA, US
Tayyaba Hasan - Boston MA, US
James Muller - Boston MA, US
Rox Anderson - Boston MA, US
David Elmaleh - Boston MA, US
Henry Gewirtz - Boston MA, US
International Classification:
A61K 49/00, A61K 39/395, C07K 16/46
US Classification:
424009600, 424178100, 530391100
Abstract:
The present invention relates to methods for selectively targeting Photodynamic Therapy (“PDT”) to inflammatory components of vulnerable plaques. As such, the present invention provides methods for the identification of vulnerable plaques, using fluorescent compositions, which include photosensitizer compoisitions, and/or radiolabeled compounds, as well as methods to treat vulnerable plaques by selectively targeting and/or eliminating the inflammatory components of vulnerable plaques.